Stephens Inc. AR purchased a new stake in Exponent, Inc. (NASDAQ:EXPO – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 2,243 shares of the business services provider’s stock, valued at approximately $259,000.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Quarry LP purchased a new stake in shares of Exponent in the 2nd quarter valued at about $25,000. GAMMA Investing LLC raised its holdings in shares of Exponent by 67.7% during the 2nd quarter. GAMMA Investing LLC now owns 379 shares of the business services provider’s stock valued at $36,000 after buying an additional 153 shares in the last quarter. Whittier Trust Co. of Nevada Inc. raised its holdings in shares of Exponent by 166.5% during the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 517 shares of the business services provider’s stock valued at $49,000 after buying an additional 323 shares in the last quarter. USA Financial Formulas purchased a new position in shares of Exponent during the 3rd quarter valued at about $60,000. Finally, Benjamin F. Edwards & Company Inc. raised its holdings in shares of Exponent by 70.5% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 873 shares of the business services provider’s stock valued at $83,000 after buying an additional 361 shares in the last quarter. Hedge funds and other institutional investors own 92.37% of the company’s stock.
Wall Street Analysts Forecast Growth
Separately, Truist Financial reissued a “buy” rating and set a $120.00 price objective (up from $100.00) on shares of Exponent in a report on Friday, July 26th.
Insider Buying and Selling
In related news, Director Paul R. Johnston sold 14,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $104.60, for a total transaction of $1,464,400.00. Following the transaction, the director now directly owns 80,742 shares in the company, valued at $8,445,613.20. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, Director Carol Lindstrom sold 1,039 shares of the firm’s stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $96.32, for a total transaction of $100,076.48. Following the transaction, the director now directly owns 5,871 shares in the company, valued at $565,494.72. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Paul R. Johnston sold 14,000 shares of Exponent stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $104.60, for a total value of $1,464,400.00. Following the completion of the sale, the director now owns 80,742 shares in the company, valued at approximately $8,445,613.20. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.10% of the stock is owned by corporate insiders.
Exponent Trading Down 0.5 %
Shares of NASDAQ EXPO opened at $104.20 on Friday. The stock has a market cap of $5.29 billion, a price-to-earnings ratio of 50.34 and a beta of 0.69. Exponent, Inc. has a 1-year low of $68.70 and a 1-year high of $115.75. The stock’s 50-day moving average is $107.71 and its 200 day moving average is $101.25.
Exponent Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, December 20th. Investors of record on Friday, December 6th will be given a dividend of $0.28 per share. The ex-dividend date of this dividend is Friday, December 6th. This represents a $1.12 annualized dividend and a yield of 1.07%. Exponent’s payout ratio is 54.11%.
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Further Reading
- Five stocks we like better than Exponent
- Insider Buying Explained: What Investors Need to Know
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- How Investors Can Find the Best Cheap Dividend Stocks
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Canada Bond Market Holiday: How to Invest and Trade
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO – Free Report).
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.